Hyperguides

Orthopaedics / Basic science

Osteomalacia

Osteomalacia Tutorial Joseph M. Lane, MD Hospital for Special Surgery, New York, New York University of Iowa, Iowa City, Iowa Thomas A. Einhorn, MD Boston University of Medical School, Boston, Massachusetts Frederick Kaplan, MD University of Pennsylvania, Philadelphia, Pennsylvania
Article

Rickets and osteomalacia

Rickets (youth) and osteomalacia (adult) result from the failure to mineralize epiphyseal cartilage, which increases the hypertrophic zone, and bone, which decreases the mineralization rate and increases unmineralized osteoid.

Features of clinical rickets include: apathy, irritability, shorter stature, positive Gowers’ test, laxity, frontal bossing, rachitic rosary, Harrison's grove, and enlarged epiphyses.

Features of clinical osteomalacia include: localized bone pain and muscle weakness. Radiographic evidence of osteomalacia include: widening of the epiphyseal plate (paint brush); cupping, indistinct zone of provisional calcification; stress fractures (Looser's lines); long leg bowing (genu valgum/genu varum).

Laboratory evidence of osteomalacia includes: normal or decreased levels of calcium; decreased phosphorous decreased (increase in renal); increased levels of alkaline phosphatase; decreased 25(OH) and vitamin D; and an increase in parathyroid hormone (PTH).

Specifically, with vitamin D deficiency and blind loop GI calcium is normal or decreased; phosphorus is decreased; PTH is increased; 25(OH) is increased; and vitamin D is decreased. In hypophosphatemic disorders, an x-linked dominant proximal tubule defect, calcium is normal; phosphorus is very decreased; PTH is normal; and 25 (OH) is normal. Renal osteodystrophy results in decreased calcium; highly increased phosphorus; very highly elevated PTH; and normal 25 (OH).

Other etiologies of osteomalacia include: barbiturate-induced renal tubular acidosis; vitamin dependency, a defect of 1-alpha-OH lase; mesenchymal tumors, anti-vitamin D factor; and aluminum osteomalacia.

The treatment for vitamin D deficiency is 1 to 50,000 daily units of vitamin D plus calcium. For vitamin D resistance, the treatment is phosphate plus 1,25(OH)2 and low vitamin D (hypophosphatemic).

The treatment for renal osteodystrophy is increased calcium; low phosphate diet being careful of phosphate binders, such as calcium carbonate; and selective parathyroidectomy 1,25(OH)2 vitamin D.

Orthopedic treatments for osteomalacia include: bracing and osteotomies of the tibial plateaus parallel to the ankle.

Bibliography

  1. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, et al. Risk factors for hip fracture in white women. study of osteoporotic fracture research group. N Engl J Med. 1995;332:767-773.
  2. Drinkwater BL, Grimston SK, Roab-Cullen DM, Snow-Harten CM. ACSM position stand on osteoporosis and exercise. Med Sci Sports Exercise. 1995;27:745-750.
  3. Favus MJ. Primer on the metabolic bone disease and disorders of mineral metabolism, 2nd edition. Philadelphia, Pa:Lippincott-Raven; 1993.
  4. Greenspan SL, Myers ER, Maitland LA, Resnick NM, Hayes WC. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA. 1994;271:128-133.
  5. Lane JM, Riley EH, Wirganowicz PZ. Osteoporosis: diagnosis and treatment. J Bone Joint Surg. 1996;78-A(4):618-632.
  6. Lane JM, Riley EH. New advances in osteoporosis: editorial review. Current Opinion in Orthopedics. 1994;5:108.
  7. Lane JM, Scaduto A. Recent advances in drug therapy for osteoporosis current opinion in orthopaedics. Current Opinion in Orthopaedics. 1995;6:6.
  8. Pak CYC, Sakhall K, Adams-Huet B, Piziak V, Peterson RD, Poindexter JR. Treatment of post menopausal osteoporosis with slow release sodium fluoride: final report of a randomized controlled trial. Annals Int Med.. 1995;123: 401-408.
  9. Riggs BL, Melton LJ. The prevention and treatment of osteoporosis. N Engl J Med. 1992;327: 620-627.